Gyre Therapeutics (GYRE) Shares Outstanding (2010 - 2026)
Gyre Therapeutics' Shares Outstanding came in at 100.64 million for Q2 2026, up 12.9% from 89.12 million a year earlier and up 10.2% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Shares Outstanding (2010 - 2026) Analysis & Trends
For FY2025, Gyre Therapeutics' Shares Outstanding was 89.34 million, up 5.0% from FY2024.
- Shares Outstanding carries a five-year compound annual growth rate of 133.8% (FY2020 to FY2025).
- Going back by year, Shares Outstanding was 85.09 million in FY2024 (+29.3%), 65.83 million in FY2023, 2.1 million in FY2022 (+3.0%) and 2.04 million in FY2021 (+59.8%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding in data going back to Q2 2010.
- Year-over-year, Shares Outstanding has increased for seven consecutive quarters, with growth averaging 9.6% over the last seven quarters.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 0.3% in Q3 2022 to 59.8% in Q4 2021.
- Business Quant data shows GYRE's Shares Outstanding at 91.32 million (Q1 2026), 89.34 million (Q4 2025) and 90.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Gyre Therapeutics | 742.24 Mn | 544.95 Mn | 26.90 Mn | 100.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.64 Mn |
| Mar 31, 2026 | 91.32 Mn |
| Dec 31, 2025 | 89.34 Mn |
| Sep 30, 2025 | 90.85 Mn |
| Jun 30, 2025 | 89.12 Mn |
| Mar 31, 2025 | 86.42 Mn |
| Dec 31, 2024 | 85.09 Mn |
| Sep 30, 2024 | 85.64 Mn |
| Jun 30, 2024 | 85.50 Mn |
| Mar 31, 2024 | 83.27 Mn |
| Dec 31, 2023 | 65.83 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 2.52 Mn |
| Mar 31, 2023 | 2.52 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 2.09 Mn |
API Access
Gyre Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();